4 results match your criteria: "Oslo University Hospital Nydalen[Affiliation]"
J Dairy Sci
February 2020
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo Blindern, Norway 0317. Electronic address:
Little is known about how dairy products with different nutrient contents and food matrices affect appetite sensation and gut hormone secretion. The objective of this study was to investigate how appetite sensation and gut hormone secretion in healthy adults are affected by meals with the same amount of fat but from different dairy products. Forty-seven healthy adults (70% women) were recruited to a randomized controlled crossover study with 4 dairy meals consisting of butter, cheese, whipped cream, or sour cream, corresponding to 45 g (approximately 60 energy percent) of fat.
View Article and Find Full Text PDFJ Anal Toxicol
March 2019
Department of Forensic Sciences, Oslo University Hospital Nydalen, Oslo, Norway.
Benzodiazepines are commonly seen in samples submitted for drug testing of patients, people involved in child welfare cases, work-place drug testing, as well as in drug-facilitated assaults. Limited previous experimental studies are available regarding the excretion of benzodiazepines in urine and oral fluid. The aim of this study was to investigate the concentrations of diazepam and alprazolam in oral fluid and urine for up to 2 weeks after ingestion of a single oral dose in healthy volunteers.
View Article and Find Full Text PDFAim: The aim of the study, being part of a Norwegian evaluation project of the RAFAELA system, was to explore nurse managers' perception of the RAFAELA system as a management tool in a Norwegian hospital setting.
Design: We applied an explorative qualitative design using focus group interviews.
Methods: Two focus group interviews were performed with 12 nurses in different management positions during autumn 2013.
Cell Death Dis
May 2017
Stem Cell Research Unit, Department of Medical Faculty, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Protein tyrosine phosphatase 1B (PTP1B) is a well-known inhibitor of insulin signaling pathways and inhibitors against PTP1B are being developed as promising drug candidates for treatment of obesity. PTP1B has also been linked to breast cancer both as a tumor suppressor and as an oncogene. Furthermore, PTP1B has been shown to be a regulator of cell adhesion and migration in normal and cancer cells.
View Article and Find Full Text PDF